July 2003

|
Volume 15 Issue 9
Stent placement across the lesion.
The First Clinical Experience with a Peripheral, Self-Expanding Nitinol Stent in the Treatment of Saphenous Vein Graft Disease:
Coronary artery bypass graft surgery (CABG) is an established form of revascularization, typically associated with improved survival. However, CABG has its own inherent deficiencies, including recurrent ischemia, venous graft failure and the need for…
Editor's Message (July 2003)
Dear Readers, This issue of the Journal of Invasive Cardiology marks the beginning of a new home for the journal and for the editor-in-chief. Management of the journal will now be coordinated from the office of the Joint Cardiac Program of Sutter He…
Transesophageal echocardiogram (TEE) of a large patent foramen ovale (PFO). The PFO is visualized via a stream of microbubbles (white arrow) passing across the atrial septum. RA = right atrium; LA = left atrium.
Successful Percutaneous Closure of Patent Foramen Ovale Seven Years After Surgical Closure
Patent foramen ovale (PFO) is a common phenomenon, affecting approximately one-quarter of the normal healthy population. The prevalence of PFO in patients with ischemic stroke is significantly higher than in the normal population.1 Many patients with…
An aortic angiogram in the lateral projection demonstrating a short and funnel-like patent ductus arteriosus with a shallow aortic ampulla. The narrowest size measured 6.5 mm.
Percutaneous Occlusion of the Patent Ductus Arteriosus with the Amplatzer Device for Atrial Septal Defects
Percutaneous occlusion of the patent ductus arteriosus (PDA) has been performed safely and effectively with different devices over the last years.1–6 Selection of the closure device is based on the anatomic configuration of the duct and its minimal d…
Duplex ultrasound of the jugular vein revealed a non-occlusive, floating thrombus formation at the tip of the displaced lead.
A Unique Pacemaker Complication of Thrombus Formation in the Right Internal Jugular Vein Due to Unusual Migration of an Atrial P
Common complications of permanent endocardial pacing systems include infection of the generator pocket, the wire track, increase in pacing threshold or complete exit block due to fibrosis at the myocardial contact site, dislocation or (rarely) intrav…
Stenosis in proximal left subclavian artery with poor filling of left internal mammary artery (LIMA) in patient #1 (arrow).
Percutaneous Treatment of Coronary Subclavian Steal Syndrome
Coronary subclavian steal syndrome is a variant of subclavian steal syndrome. It consists of obstructive atherosclerotic disease of the proximal subclavian artery in the presence of a patent internal mammary artery that has been previously used as an…
Prospective Evaluation of Early Abciximab and Primary Percutaneous Intervention for Patients with ST Elevation Myocardial Infarc
Cardiogenic shock occurs in about 10% of hospitalized patients with acute myocardial infarction (AMI).1 Despite the use of early reperfusion therapies with thrombolysis or percutaneous coronary intervention (PCI), the mortality in these patients rema…
Percutaneous Closure of Secundum Atrial Septal Defect in Adults — A Single Center Experience with the Amplatzer Septal Occluder
Atrial septal defect (ASD) is one of the most common congenital cardiac anomalies encountered in adults.1 Surgical ASD closure leads to improved functional status, reduces the risk of progressive right-sided failure and prevents the development of se…
Catheter Closure of Atrial Septal Defects
Since the initial description in the mid 1970s by King and Mills et al.1–3 of an atrial septal defect occluding device, a number of other devices have been studied, including: Rashkind’s devices (hooked and double umbrella), Clamshell occluder, butto…
Histogram for the overall age distribution and the current smokers’ age distribution.
Bivalirudin in Peripheral Vascular Interventions: A Single Center Experience
Unfractionated heparin (UFH) is the current antithrombotic agent utilized during peripheral angioplasty procedures (PTA). UFH has an unpredictable anticoagulation response, is an indirect thrombin inhibitor, does not inhibit bound thrombin and activa…